Comment on: Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial

Pharmacoeconomics. 2018 Oct;36(10):1297. doi: 10.1007/s40273-018-0700-z.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Clinical Trials as Topic*
  • Cost-Benefit Analysis
  • Data Interpretation, Statistical